Category: Health Canada News
-
Cholesterol Drug Zetia May Cause Serious Liver Injury Including Hepatitis And Liver Failure
Health Canada First Raised This Zetia Safety Issue In February 2005; News Reporter Discovers In December 2007 That Information Known By Merck and Schering-Plough About These Zetia Side Effects May Have Been Withheld (Posted…
-
Will New Black Box Warning About Heart Attacks Lead GlaxoSmithKline To Withdraw Avandia From Market?
One Wonders Whether GSK Might Do A "Soft" Recall Of Its Embattled Diabetes Drug, As Was Done By BMS With Serzone And Tequin In Recent Years (Posted by Tom Lamb at DrugInjuryWatch.com) Avandia (rosiglitazone)…
-
Trasylol Sales In U.S. And Canada Suspended Temporarily By Bayer In Early November 2007
Market Withdrawal Or Recall Of Trasylol Seems Possible As Bayer Waits For Final Data From Halted BART Study (Posted by Tom Lamb at DrugInjuryWatch.com) On November 5, 2007 the FDA announced and Health Canada…
-
Health Canada Provides 2007 Update On Reports Of Suspected Meridia Adverse Reactions
Meridia Can Increase Blood Pressure And Heart Rate Leading To Possible Serious Cardiovascular Problems (Posted by Tom Lamb at DrugInjuryWatch.com) The Canadian Adverse Reaction Newsletter (CARN) released in October 2007 (Volume 17, Issue 4)…
-
Health Canada Issues Ketek MedEffect Alert In Early September 2007
Antibiotic Ketek Restricted To Certain Types Of Pneumonia; No Longer Used For Sinusitis, Bronchitis, Tonsillitis, Pharyngitis (Posted by Tom Lamb at DrugInjuryWatch.com) On September 5, 2007 Health Canada issued by email a MedEffect alert…
-
Parkinson’s Disease Drug Permax Ordered Off The Market By Health Canada
Permax Was Voluntarily Withdrawn From the U.S. Market Earlier This Year At The Insistence of FDA (Posted by Tom Lamb at DrugInjuryWatch.com) As you may recall, the Parkinson disease drug Permax was voluntarily withdrawn…
-
FDA / Health Canada: Long Term Use Of Nexium And Prilosec May Cause Heart Attacks Or Cardiac Death
AstraZeneca Study Information Provided To Regulatory Agencies In May 2007 Currently The Subject of Their Ongoing Safety Reviews (Posted by Tom Lamb at DrugInjuryWatch.com) On August 9, 2007 the FDA and Health Canada issued…
-
Levaquin Associated With Blood Sugar Problems And Liver Disorders
January 2007 Article Sets Forth Reports Made To Health Canada In Past Ten Years (Posted by Tom Lamb at DrugInjuryWatch.com) The January 2, 2007 edition of the Canadian Adverse Reaction Newsletter (Volume 17, Issue…
-
New Birth Control Patch Warnings In Canada About Being Overweight, Sauna Or Whirlpool Heat
No Similar Changes To Ortho Evra Label In U.S. As Of Early December 2006 On November 23, 2006 Health Canada released a drug safety alert — which consisted of a so-called "Dear Doctor" letter…
-
Health Canada’s MedEffect Now Offers Online Reporting Of Adverse Drug Reactions
Objective Is To Increase Percentage Of ADRs That Get Reported To Regulators In October 2006 Health Canada announced that its MedEffect web site is now able to accept online reports of suspected adverse drug…